| Advantages | By retaining key molecular features of their tissue of origin, these organoids provide a physiologically relevant platform for studying gallbladder biology, epithelial regeneration, and disease progression. They are well-suited for disease modeling, drug screening, and translational research in hepatobiliary medicine. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Growth Properties | Embedded 3D Culture |
| Growth Conditions | Cultured at 37°C under 95% air and 5% CO2. |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Gallbladder |
| Disease | Normal |
| Format | Frozen |
| Organoid Characterization | They have been validated through histopathological analysis, stable multi-generational expansion, and long-term culture performance. |
| Applications | Tissue-derived organoids are broadly used in drug screening, disease modeling, mechanistic studies, personalized medicine, and regenerative medicine. By authentically modeling disease states, they provide an ideal platform for evaluating patient-specific responses to novel therapeutics and guiding personalized treatment strategies. Additionally, these organoids drive the development of innovative therapeutic approaches, particularly in cancer research and tissue regeneration, delivering precise experimental tools that significantly advance precision medicine. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.